Driehaus Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184M | Buy |
|
|||||
|
2025
Q1 | $209M | Buy |
|
|||||
|
2024
Q4 | $314M | Buy |
|
|||||
|
2024
Q3 | $301M | Sell |
|
|||||
|
2024
Q2 | $274M | Buy |
|
|||||
|
2024
Q1 | $245M | Buy |
|
|||||
|
2023
Q4 | $179M | Sell |
|
|||||
|
2023
Q3 | $153M | Sell |
|
|||||
|
2023
Q2 | $95.5M | Buy |
|
|||||
|
2023
Q1 | $84.9M | Sell |
|
|||||
|
2022
Q4 | $103M | Sell |
|
|||||
|
2022
Q3 | $111M | Buy |
|
|||||
|
2022
Q2 | $102M | Buy |
|
|||||
|
2022
Q1 | $109M | Buy |
|
|||||
|
2021
Q4 | $136M | Buy |
|
|||||
|
2021
Q3 | $63.1M | Buy |
|
|||||
|
2021
Q2 | $51M | Buy |
|
|||||
|
2021
Q1 | $30.6M | Buy |
|
|||||
|
2020
Q4 | $20.5M | Buy |
|
|||||
|
2020
Q3 | $13.7M | Sell |
|
|||||
|
2020
Q2 | $15.5M | Buy |
|